J&J Loses Trial Over Risperdal and Male Breast
The Wall Street Journal Pharmalot Blog 2015-02-24 In a setback to Johnson & Johnson, a Philadelphia jury decided the health care giant must pay $2.5 million in damages for failing to warn that its Risperdal antipsychotic could cause gynecomastia, which is abnormal development of breasts in males. The lawsuit was brought by the family of […]
J&J to Pay at Least $2.5 Billion to Settle Hip Lawsuits
The Wall Street Journal 2013-11-19 The Wall Street Journal reports that Johnson & Johnson has agreed to pay at least $2.5 billion to settle nearly 8,000 hip implant lawsuits In its latest multibillion-dollar legal settlement, Johnson & Johnson has agreed to pay at least $2.5 billion to resolve thousands of lawsuits filed by patients who […]
OIG Medicare/Medicaid Whistleblower Fraud Alert and WSJ on physician medical device distributorship
The Wall Street Journal 2013-07-26 The Wall Street Journal today published a front page story on the Department of Justice investigation into fraud in physician-owned distributorships of medical devices. Some instances of this type of Medicare/Medicaid fraud is reported by whistleblowers with representation of whistleblower law firms including Sheller, P.C. Healthcare and other professionals who […]
